Bullous and Nonbullous Pemphigoid Associated With Prurigo Nodularis: Successful Treatment With Dupilumab
- 2 July 2025
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (12) , 2346-2348
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case seriesBritish Journal of Dermatology, 2024
- Bullous pemphigoid developed after dramatic improvement of severe prurigo nodularisAnais Brasileiros de Dermatologia, 2023
- Dupilumab for the treatment of prurigo nodularis: A systematic reviewFrontiers in Immunology, 2023
- Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case seriesJournal of the American Academy of Dermatology, 2020
- Nonbullous pemphigoid: A systematic reviewJournal of the American Academy of Dermatology, 2018